STAT6 gain-of-function variant exacerbates multiple allergic symptoms
Authors:
- 17 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 151 (5) , 1402-1409.e6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targetsArchives of Dermatological Research, 2019
- Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and functionHaematologica, 2018
- Primary atopic disordersJournal of Experimental Medicine, 2018
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseasesJournal of Allergy and Clinical Immunology, 2016
- Activating STAT6 mutations in follicular lymphomaBlood, 2015
- CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sitesBioinformatics, 2014
- B‐cell‐intrinsic STAT6 signaling controls germinal center formationEuropean Journal of Immunology, 2014
- Epithelial Cell-Derived IL-25, but Not Th17 Cell-Derived IL-17 or IL-17F, Is Crucial for Murine AsthmaThe Journal of Immunology, 2012
- Activation of STAT6 by STING Is Critical for Antiviral Innate ImmunityCell, 2011
- Genetic Linkage of Hyper-IgE Syndrome to Chromosome 4The American Journal of Human Genetics, 1999